• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod: NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Klinisk medicin och internmedicin
    3. Hjärt- och kärlsjukdomar

    Evolving Challenges in Promoting Cardiovascular Health, Volume 1254

    AvValentin Fuster

    Häftad, Engelska, 2012

    Del 108 i serien Annals of the New York Academy of Sciences

    1 511 kr

    Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.

    Beskrivning

    This Annals volume stems from the two-day conference "Evolving Challenges in Promoting Cardiovascular Health" sponsored by The New York Academy of Sciences, "la Caixa" Foundation, and the International Center for Scientific Debate (ICSD), which took place November 4-5, 2011 in Barcelona, Spain.  Leading and emerging investigators working on the fields of cardiology, vascular disease, inflammation, metabolic disorders, hematology, imaging, regenerative medicine, stem cell research, epidemiology, and nutrition, among others, address novel issues, current challenges, and future directions in the prevention, treatment, and management of the evolving global epidemic of cardiovascular disease. The papers in this volume explore the promotion of cardiovascular health through molecular biology, clinical pathophysiology, and population research. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.1111/(ISSN)1749-6632.ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.

    Produktinformation

    • Utgivningsdatum:2012-07-10
    • Mått:178 x 254 x 8 mm
    • Vikt:390 g
    • Format:Häftad
    • Språk:Engelska
    • Serie:Annals of the New York Academy of Sciences
    • Antal sidor:252
    • Förlag:John Wiley and Sons Ltd
    • ISBN:9781573318594

    Utforska kategorier

    • Hjärt- och kärlsjukdomar inom Medicin

    Mer om författaren

    Valentin Fuster, MD, PhD, former Chairman of the American Heart Association's Committee on Vascular Lesions, Assessing and Modifying the Vulnerable Atherosclerotic Plaque explores the most cutting-edge developments in a field grown richer through technological advances.

    Innehållsförteckning

    • 1. Cardiovascular defense challenges at the basic, clinical, and population levelsJason C. Kovacic, Jose M. Castellano, and Valentin Fuster7. Plaque neovascularizationl defense mechanisms, betrayal, or a war in progressPedro R. Moreno, Meeranani Purushothaman, and K-Raman Purushothaman18. LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaosLina Badimon and Gemma Vilahur33. Evolving role of molecular imaging for new understanding: targeting myofibroblasts to predict remodelingHans J. de Haas, Susanne W. van den Borne, Hendrikus H. Boersma, Riemer H.J.A. Slart, Valentin Fuster, and Jagat Narula42. Molecular targets in heart failure gene therapy: current controversies and translational perspectivesVictor Kairouz, Larissa Lipskaia, Roger J. Hajjar, and Elie R. Chemaly51. Engineered arterial models to correlate blood flow to tissue biological responseJordi Martorell, Pablo Santomá, José J. Molins, Andrés A. García-Granada, José A. Bea, Elazer R. Edelman, and Mercedes Balcells57. A bird’s-eye view of cell therapy and tissue engineering for cardiac regenerationCarolina Soler-Botija, Juli R. Bagó, and Antoni Bayes-Genis66. Umbilical cord blood for cardiovascular cell therapy: from promise to factSantiago Roura, Josep-Maria Pujal, and Antoni Bayes-Genis71. Heart repair: from natural mechanisms of cardiomyocyte production to the design of new cardiac therapiesSilvia Martin-Puig, Valentín Fuster, and Miguel Torres82. Energy metabolism plasticity enables stemness programsClifford D.L. Folmes, Timothy J. Nelson, Petras P. Dzeja, and Andre Terzic90. The future: therapy of myocardial protectionDavid Sanz-Rosa, Jaime Garcia-Prieto, and Borja Ibanez99. The links between complex coronary disease, cerebrobascular disease, and degenerative brain diseaseJason C. Kovacic, Jose M. Castellano, and Valentin Fuster106. Optimal lipid targets for the new era of cardiovascular preventionVimal Ramjee, danny J. Eapen, and Laurence S. Sperling115. Controversies in blood pressure goal guidelines and masked hypertensionRobert A. Phillips123. Evolving diagnostic and prognostic imaging of the various cardiomyopathiesJavier Sanz131. The evolving landscape of quality measurement for heart failureAshley A. Fitzgerald, Larry A. Allen, and Frederick A. Masoudi140. Atrial Fibrillation, Stock, and quality of lifeJason S. Chinitz, Jose M. Castellano, Jason C. Kovacic, and Valentin Fuster151. Transcatheter aortic valve implantation and cerebrovascular events: the current state of the artBrian G. Hynes and Josep Rodés-Cabau164. Are we ignoring the dilated thoracic aortia?Jose M. Castellano, Jason C. Kovacic, Javier Sanz, and Valentin Fuster175. Corrigendum